Please login to the form below

Not currently logged in

Cardioxyl Pharma

This page shows the latest Cardioxyl Pharma news and features for those working in and with pharma, biotech and healthcare.

BMS agrees to buy Cardioxyl for heart failure drug

BMS agrees to buy Cardioxyl for heart failure drug

BMS agrees to buy Cardioxyl for heart failure drug. Willpay up to $2bn for the US-based company. ... BMS has agreed to buy Cardioxyl Pharma in a transaction valued at up to $2bn that would give it rights to a heart failure drug in phase II trials.

Latest news

More from news
Approximately 1 fully matching, plus 0 partially matching documents found.

Featured jobs

Subscribe to our email news alerts


Add my company
Anthill Agency

Digital communications agency empowering clients through their digital transformation journey. Whether through training, delivering solutions or devising digital strategies, we...

Latest intelligence

World Diabetes Day: Interaction and impact of diabetes on mental health
For World Diabetes Day on the 14th November 2018, Nisha Shahrukh - Medical Writer at Mednet Group has written an article depicting the impact diabetes has on mental health. Including...
Innovation in merger control and the impact on the pharmaceutical sector
Is focusing on pipeline products enough to assess regulatory risks?...
Nudge-nudge, think-think
Chris Ross examines the personal complexities of human behaviour – and explains why fun, emotion and peer endorsement could be key to designing effective behavioural change programmes...